[Clinical experience in the use of orciprenaline (Alupent) as an inhibitor of uterine contractility].
D000293:Adolescent; D000328:Adult; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009921:Metaproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010627:Phenethylamines / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012118:Resorcinols / Q000627:therapeutic use*; D014599:Uterus / Q000187:drug effects*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol
Experiencia clínica con el uso de la orciprenalina (Alupent) como inhibidor de la contractilidad uterina.